Information security incident occurred at Granules India

Hyderabad: Granules India has announced that an information security incident has occurred at the Company and the impacted IT assets have been isolated.

"The Company is investigating the matter with utmost priority," the Company informed in a recent BSE filing.

"The appropriate containment and remediation actions are being taken in a controlled manner to address the incident," Granules stated.

Read also: Indian-origin men convicted of running large-scale fake pharma drugs factory, money laundering in UK

Medical Dialogues team had earlier reported a similar incident when an information security incident had occurred at Sun Pharma.

Read also: Information security incident occurred at Sun Pharma, impacted IT assets isolated

Granules India Limited, incorporated in 1991 is a vertically integrated Indian pharmaceutical company headquartered at Hyderabad. Granules is among the few pharmaceutical companies in the world to be present in the manufacturing of entire value chain – from Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs). Its products are being distributed to over 300+ customers in regulated and semi-regulated markets with a global presence extending to over 80+ countries with offices across India, US, and UK. The Company has 7 manufacturing facilities out of which 6 are in India and 1 in the USA and has regulatory approvals from US FDA, EDQM, EU GMP, COFEPRIS, WHO GMP, TGA, K FDA, DEA, MCC, and HALAL.

Read also: Granules India reports 7.8 percent rise in Q4 profit